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An Assistive Coughing Device for
Post-Laryngectomy Patients
Keren Yue, Henry Lancashire, Kylie de Jager, James Graveston, Martin Birchall, Anne Vanhoestenberghe,
Andrew Conn, Jonathan Rossiter
Abstract—People who have undergone total laryngectomy
typically have difficulties speaking and coughing. Coughing,
the protective reflex action where air is rapidly expelled from
the lungs to clear the airway, is crucial in everyday life.
Insufficiency in coughing can lead to serious chest infections.
In this research we present a bionic assistive coughing device
(RoboCough) to improve coughing efficacy among laryngectomy
patients by increasing pressure and flow rate. RoboCough was
designed to mimic the function of the glottis and trachea in the
upper respiratory system. Experimental results show a significant
increase (t(64) = 4.9, p < 0.0001) in peak cough flow rate and
peak cough pressure (t(64) = 12.6, p < 0.0001) among 33 control
participants using RoboCough. A pilot study with a smaller co-
hort of laryngectomy patients shows improvement in peak cough
pressure (p = 0.0159) using RoboCough. Preliminary results also
show that post-laryngectomy coughs achieved similar peak cough
flow (Z = -0.9933, p = 0.32) to the control group’s natural
cough. Coughing capabilities could be improved through using
RoboCough. Applications of RoboCough include simulation of
vocal folds and respiratory conditions, rehabilitation of ineffective
coughs from laryngeal and respiratory diseases and as a test-bed
for the development of medical devices for respiratory support.
I. INTRODUCTION
CANCER Research UK statistics reported around 11,900new cases of head and neck cancers yearly between
2014-2016 [1]. Treatments of laryngeal cancer varies depend-
ing on the pathology. Total laryngectomy is indicated for the
curative treatment of laryngeal cancer where the tumour is
considered to be too advanced for radiotherapy or partial
resection. Speech and coughing problems are significantly
higher among patients with total laryngectomy compared to
partial laryngectomy patients [2].
Total laryngectomy is a procedure that involves the removal
of the entire larynx and the upper tracheal cartilage rings [3].
Post laryngecotomy patients are no longer at the risk of
aspiration pneumonia, however some patients have difficulties
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Fig. 1. (a) Three phases of coughing in healthy people. (b) Coughing
in laryngectomy patients is limited by the lack of a functional glottis. (c)
Proposed cough assistive device.
in coughing. Coughing in healthy subjects, as can be seen
from Fig 1a, typically involves three phases: inhalation, com-
pression and exhalation. In inhalation phase, air is inhaled and
expiratory muscles are engaged; In compression phase, glottis
is closed, expiratory muscles contract, allowing intrathoracic
pressure to build up in the airway; In exhalation phase, glottis
opens and a rapid exhalation follows [4]. Expiratory pressure
and flow profiles during coughs are shown in Fig 2. Cough is
vital for clearing excessive secretions in the airway. However,
the absence of the glottis in post-laryngectomy patients, and
the direct exit of the trachea through the stoma, causes reduced
cough efficiency (Fig 1b), such that daily sputum production,
coughing and the need for frequent forced expectoration are
among the most common complaints made by patients [5].
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Fig. 2. Flow rate and respiratory mouth pressure during three consecutive coughs by participants with a single cough profile enlarged on the right.
Although some patients find limited relief through the use
of heat and moisture exchangers, which condition inspiratory
air and thereby treating pulmonary symptoms and aid stoma
cleaning [6], the coughing ability of post-laryngectomy pa-
tients is far below healthy people.
Clinically there are many potential factors that can be used
to assess cough efficiency. For example, maximal respiratory
mouth pressure and coughing gastric pressure are typically
used to assess the strength of expiratory muscles [7], which are
associated with coughing effectiveness [8]. The effectiveness
of a cough can also be affected by the adhesion and cohesion
of mucus [9], [10]. By simulating cough flow rates using a
pressurized chamber, the influences of rheological properties
on mucus clearance have been investigated [11]. Mechanical
experiments have also shown that increasing the pressure and
flow rate improves mucus clearance [12], and that increase in
expiratory flow and pressure can be achieved using mechan-
ical assistance for patients with motor-neuron diseases [13].
Studies show for effective mucus expectoration, peak cough
flow (PCF) must exceed 160 to 200 L/min [14], [15]. PCF
above 250 to 270 L/min could prevent pneumonia in patient
with neuromuscular disorders [15], [16]. For laryngectomised
patients, a lack of signals arising from the larynx may result
in a reduction of cough volume acceleration and the intensity
of abdominal muscle contractions during a reflex cough.
These factors may contribute to facilitate the onset and/or the
persistence of chest infections [17].
Medical robotics has advanced rapidly through past decades,
from surgical robots such as the da Vinci surgical system
and surgical tools developed for minimal invasive surgeries,
to rehabilitation exoskeletons and implantable robotics such
as heart sleeves [18] and drug delivery robots [19]. Despite
this growth, there has been a dearth of research into robotics
to assist respiratory conditions and, more specifically, cough
insufficiency. Current cough augmentation methods generally
fall into three categories: Mechanical insufflation-exsufflation
(MI-E) technique such as Cough Assist, where a positive
pressure is applied during inhalation and a fast negative
pressure is applied for exhalation to improve cough, and
rehabilitation devices to improve the cough flow [20]; In-
termittent positive-pressure breathing (IPPB) devices which
provide a constant positive pressure during the inhalation
phase followed by a passive exhalation phase where the
positive pressure returns to atmospheric, thereby improving
cough capacity by increasing the inhalation volume [21]; and
manually assisted coughing (MAC), where abdominal thrust or
lateral costal compression is applied. Although these devices
can effectively increase cough efficiency, they have a central
limitation of poor portability and cannot be used during day-
to-day activities. Additionally, most of the current devices are
used in primary care settings and are operated by a care giver.
Consequently, there is a large unmet need for cough assist
devices in secondary and at-home care and there are currently
no commercial devices available that offer independent user
control and sufficient mobility for use during activities of daily
living.
To overcome these limitations, we propose a highly portable
user-operated device (Fig 1c) to improve cough sufficiency,
which takes over glottal control while acting as an autonomous
bionic “organ”. In this research a preliminary design of the
RoboCough coughing device, that mimics the function of the
glottis in the respiratory system, was built and tested.
II. METHODS
Increased coughing efficiency is indicated by either an
increased gastric pressure or an increased Peak Cough Flow
rate (PCF), which can be achieved by increasing the expiratory
muscle strength or by increasing the pressure resistance of the
vocal folds.In this study we focus primarily on the function
of the vocal fold area and hence expiratory pressure (peak
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Fig. 4. Photograph of the RoboCough test and evaluation system.
cough pressure) and peak cough flow rate were measured
and analysed. RoboCough is designed to have the following
characteristics: fast opening and closing (< 30 ms [22]), air-
tight closure (able to withstand pressures up to 200 cmH2O),
pressure-based feedback-controlled opening, fail safe opening
mechanism and patient override.
A. Design of RoboCough
Fig 3a shows the RoboCough system design. Fig 4 shows a
photograph of the device. A disposable cardboard mouthpiece
was used to connect to an anti-bacterial and anti-viral filter
(BIOPAC, AFT4 VBMax, 35mm), which was then connected
to a normally open solenoid valve (ASCO SCE210C35, NO,
3/4in) via a respiratory tube (22mm diameter). For laryn-
gectomy patient studies, a personalised 3D printed stoma
adaptor was used in place of the cardboard piece to ensure
an airtight connection around stoma. An example is shown
in Fig 5, this stoma adaptor has a diameter of 26mm, and
consists of a polylactic acid (PLA) component that push fit
onto a standard medical-grade silicone stoma skin barrier.
The solenoid valve was used to mimic the human glottis
function during coughing. High speed photography analysis
have shown the glottis opening time during is around 25-30
ms [22]. The chosen valve could achieve a comparable fast-
opening time (15ms at fastest) which is also portable, low-cost
and can maintain high pressure (9 bar), showing advantage
over alternative valve types such as butterfly or ball valves,
which are larger, slower or have lower maximum pressures.
The solenoid valve’s orifice diameter is 19mm and its flow
coefficient, Kv , is 4.7m3/h. The estimated pressure loss ∆p
caused by the valve can be calculated using the equation below,






where Q is the flow rate and SG is the specific gravity
(0.0012 for air at 20°). For the selected valve, average ∆p
is estimated to be 0.008 bar at average testing flowrate
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Fig. 6. System state diagram relative to user input, where states S1,S2 and
S3 correspond to the phases of inhale, compression and exhale (cough) shown
in Fig 2, and valve states are represented by [0] for close and [1] for open.
State transitions are governed by pressure threshold pth and button presses.
range. The pressure is monitored in real time by a pressure
sensor (Honeywell SSCSNBN015PDAA5) in the respiratory
tube before the valve, approximating peak cough pressure.
The valve controls the air flow by sealing and building up
pressure in the respiratory tube. During the inhalation phase,
the valve opens, allowing air to be inhaled by participants.
In the compression phase, the valve is activated and closes,
allowing pressure to build up. In the exhalation phase, the
valve opens again allowing air to be rapidly expelled. The
valve automatically opens when pressure reaches a certain
threshold (pth), mimicking the way vocal folds open during
human cough. A Pneumotachometer (TSD137H) is attached
to the expiratory flow end of the RoboCough to record cough
flow rate using a BIOPAC MP150 data acquisition system.
All tubing are of standard size (22mm) that used in clinical
settings. Since pressure thresholds can vary from person to
person and as coughing conditions vary, a dial located on the
control box allows participants to alter the pressure threshold
pth to a comfortable value. A manual override is available
using two buttons on the control box (Bclose for closing and
Bopen for opening the solenoid) so that users can immediately
adjust the valve’s state at any time if they are not comfortable
(this option was not observed during any of the tests in this
study). The operation of the RoboCough, shown in Fig 6,is
as follows: 1. The valve is open and the user inhales fully,
(S1, valve [1]). 2. The valve is closed when the user presses
the Bclose button (S2, valve [0]), replicating the closing of
the glottis in preparation for a cough. 3. The user increases
pressure in their lungs against the closed valve, generating the
pressure needed for the cough. 4. When the pressure measured
in the respiratory tube reaches pth the valve opens, rapidly
releasing the pressurised air in the lungs and initiating an
artificial cough, (S3, valve [1]). At any time, the user can
press the Bopen button and RoboCough will immediate enter
safe state S1.
B. Ethical Approvals
Ethical approval was obtained for this study from the
University of Bristol Engineering Faculty Research Ethics
Committee (ID:84502), and the University College London
Research Ethics Committee (ID: 5697/006). Informed consent
was sought from all participants before their involvement in
the study following UoB and UCL guidance.
C. Subjects
33 control participants were recruited at University of
Bristol and University College London (24 male and 9 female:
ages 24 to 48, median age 28). Inclusion criteria for control
participants were: any person between the age of 18 to 64,
who does not have any condition or disease affecting their
voice, and does not have any neuromuscular disorder. 5 post-
laryngectomy participants were recruited at University College
London (4 male and 1 female, ages 53 to 79, median age 72).
A power calculation was carried out using the software
package “G*Power 3.1.9.2” [24] and data from an n = 5
control and m = 5 post-laryngectomy participant pilot study
was used. Two tailed Wilcoxon signed-rank tests assumed,
alpha = 0.05, beta = 0.8. A minimum sample size of 28
control participants was calculated for the difference in medi-
ans between RoboCough and voluntary coughs. A minimum
sample size of 4 post-laryngectomy participants was calculated
for the difference in peak cough pressure medians between
RoboCough and voluntary cough, and 69 post-laryngectomy
participants was calculated for the difference in peak cough
flow medians between RoboCough and voluntary cough.
Availability of post-laryngectomy participants restricted this
group to m = 5.
D. Experiments
Experiments were carried out with n = 33 control partic-
ipants and a pilot study was carried out with m = 5 post-
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laryngectomy participants to test the effectiveness of Robo-
Cough. Peak Cough Flow (PCF, L/min), Peak Cough Pres-
sure (PCP, cmH2O) and expiratory acceleration (L/s2) were
measured during voluntary cough and RoboCough assisted
cough. Results were compared between the control and the
post-laryngectomy group. In both voluntary and RoboCough
cough tests, the control group was provided with a mouthpiece
whereas the post-laryngectomy group was provided with a 3D
printed adapter which ensured a good seal around the stoma.
Both groups were asked to breath in and out naturally through
the mouthpiece/adapter several times to relax and to familiarise
themselves with the device.
Participants were first asked to cough voluntarily with the
valve kept open, giving a baseline for a peak voluntary cough.
They were then asked to emulate a cough using RoboCough
by performing a peak expiration manoeuvre. In both tests
participants were asked to cough five consecutive times into
the device. In tests using RoboCough, the cough pressure
threshold was set by each participant to a level that they found
comfortable.
In voluntary cough tests, the participant was instructed to
cough as forcefully as they could (patient group users exhaled
as forcefully as possible if unable to cough). In RoboCough
cough tests, pressure threshold (pth) were fine tuned by each
participant using the dial. Detailed instructions were given
and participants were given time to tune the dial and attempt
coughs at different pressure thresholds until they found a pres-
sure threshold for which they could cough comfortably. For
the control group, three different threshold settings were tested
to ascertain its effect on cough effectiveness. Participants were
asked to tune the threshold to mimic the situation of a “strong
cough”, that is to cough using maximum effort. Then the
threshold was tuned down to a medium level, to mimic the
condition of a moderate cough. The threshold was then tuned
down further to a point where participants felt it easy to cough,
analogous to an instance of “throat clearing”. In the patient
group, only one threshold setting was tested for safety reasons,
when it felt most comfortable and natural to cough through
the device.
E. Statistical analysis
All results are presented as mean ± standard deviation
or median ± interquartile range where appropriate. Paired t-
tests were used to determine differences in mean response to
voluntary and RoboCough cough within the control group.
Alpha cutoff was set to 0.05. Wilcoxon rank-sum tests were
used to determine differences in mean response to voluntary
and RoboCough cough within the post-laryngectomy group.
III. RESULTS
Fig 7 and Fig 8 show a sample coughing profile of one
participant from the control group and one from the post-
laryngectomy group. It can be seen from the graphs that when
comparing voluntary and RoboCough coughs, RoboCough
generates a higher peak flow rate and a higher peak cough
pressure, and takes a longer time to return to baseline. It
is to be noted that the peak cough pressure measured in












































Fig. 7. Example cough flow and pressure profiles from control group during
voluntary and RoboCough assisted cough.











































Fig. 8. Example cough flow and pressure profiles from post-laryngectomy
group during voluntary and RoboCough assisted cough.
voluntary coughs is equivalent to MEP, while that recorded
in RoboCough coughs is equivalent to glottal pressure. Cough
acceleration, calculated as the ratio of cough peak flow to the
time to peak, represented as the gradient rise to peak cough
flow [25], [26], was also higher in RoboCough coughs.
In RoboCough experiments, only pressure and flow rate
data were collected using the BIOPAC system. The pressure
threshold was back-calculated from pressure and flow rate
profiles based on the fact that the valve will only open
when the pressure threshold is reached. It is assumed that the
threshold pressure is reached when exhalation begins. To take
into account delays in system processing and valve opening, a
constant 80ms delay was assumed between reaching pth and
the RoboCough actuating.
Table I summarizes the mean PCF, PCP and cough accel-
eration in all control group tests. As compared with voluntary
coughs, all RoboCough tests generate higher mean PCF, PCP
and acceleration. Within the RoboCough tests, the value of all
parameters were seen to increase with pressure threshold.
Fig 9 shows how PCF and PCP increase with the use of
RoboCough in control group, with illustrative lines marking
0, 100, 200 and 300% increase. It can be seen that PCP
was greater during RoboCough cough (94.4±32.7 cmH2O)
than during voluntary cough (19.8±4.0 cmH2O) (paired t-
test, t(64)=12.6, p<0.0001). PCF increased during RoboCough
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TABLE I
SUMMARY OF COUGHING CHARACTERISTICS IN CONTROL GROUP. (BOLD SHOWS STATISTICALLY SIGNIFICANT DATA.)
Peak Cough Flow (L/min) Peak Cough Pressure (cmH2O) Acceleration (L/s2)
Voluntary Cough 236.8 ± 69.5 19.8 ± 4.0 45.3 ± 13.5
Low pth RoboCough 279.3 ± 67.1 58.8 ± 18.2 74.2 ± 14.1
Medium pth RoboCough 290.6 ± 74.3 69.1± 22.1 78.5 ± 14.5
High pth RoboCough 329.1 ± 82.9 94.4 ± 32.7 91.0 ± 19.0
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Fig. 9. Mean peak cough flow (PCF) and peak cough pressure (PCP) with and without using RoboCough in control participants.
TABLE II
COUGHING CHARACTERISTICS IN POST-LARYNGECTOMY GROUP. (BOLD SHOWS STATISTICALLY SIGNIFICANT DATA.)
Peak Cough Flow (L/min) Peak Cough Pressure (cmH2O) Acceleration (L/s2)
Voluntary Cough 182.3 ± 86.9 11.9 ± 6.5 36.4 ± 14.6
RoboCough 226.5 ± 141.4 46.2 ± 29.3 115.9 ± 165.9
cough (329.1±82.9 L/min) compared with during voluntary
cough (236.8±69.5 L/min) (paired t-test, t(64) = 4.9, p <
0.0001). Comparison between mean PCP and PCF with and
without using RoboCough show that PCF increase can be
found in 25/33 participants while PCP has increased signif-
icantly (p < 0.0001) in all participants. Peak cough flow
differences before and during using RoboCough are further
shown in Fig 11. Cough acceleration is also evaluated since
it is one indicator on an effective cough. It has also increased
significantly (t(64) = 4.39, p<0.01) using RoboCough, as
shown in Table I.
Table II tabulates the mean PCP and PCF value in laryngec-
tomy participants with and without RoboCough. Fig 10 shows
how PCF and PCP increase with the use of RoboCough in
the post-laryngectomy group, with illustrative lines marking
0, 100, 200, 300% increase. In these RoboCough tests, only
one comfortable pressure threshold was set and tested for
each post-laryngectomy participant. A Wilcoxon rank sum test
shows a significant increase in pressure (p = 0.0159) with and
without using RoboCough whereas peak flow (p = 1) does not
show notable differences among the cohort. Results show an
improvement in flow rate in 3/5 post-laryngectomy participants
as can be seen more clearly from the ordered data in Fig 11.
When comparing data from post-laryngectomy group to
control group, using the RoboCough, post-laryngectomy
coughs also reached similar peak cough flow to the control
group’s natural cough (Wilcoxon rank sum test, Z = -0.9933,
p = 0.32), and achieved higher peak cough pressure (Wilcoxon
rank sum test, Z = 2.6775, p = 0.0074).
IV. DISCUSSION
In this study all cough data was analysed and there was no
subjective data selection post experiments. The data collected
therefore shows the natural dynamics of a series of volun-
tary and RoboCough coughs. We found that the RoboCough
coughing assist device improved peak cough pressure and
peak cough flow rate. The average percentage increase in
peak flow rate was observed at 49% (paired t-test, t(64)=4.9,
p<0.0001) in control group and 20% (Wilcoxon rank sum
test, p = 1) in the post-laryngectomy group, while the average
percentage increase in peak cough pressure was observed at
467% (paired t-test, t(64)=12.6, p<0.0001) in control group
and 281% (Wilcoxon rank sum test, p = 0.0159) in the post-
laryngectomy group. Note that the pressure sensor is located
before the valve but after all tubing in the system. Mea-
sured pressure is therefore equivalent to expiratory pressure
at the mouth in voluntary coughs and gastric pressure in
RoboCough coughs. An effective cough can be dependent
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Fig. 10. Mean peak cough flow (PCF) and peak cough pressure (PCP) with and without using RoboCough in post-laryngectomy participants.










































































Fig. 11. Difference in mean Peak Cough Flow in Control Group (Left) and Laryngectomy Group (Right), after using RoboCough.
on several factors, including expiratory airflow rate, gas-
mucus interactions, mucus properties, the inhalation volume
and expiratory muscle strengths [4], [27]. Studies show that
inhaling high volumes, combined with glottis closure prior
to the expiration phase, could enable respiratory muscles to
generate high intrathoratic pressures. This pressure acts as a
high driving force for the airflow during cough and hence
contributes to high peak flow rate [27]. In the absence of the
larynx (eg: laryngectomy, tracheotomy), coughing can still be
generated with low airfow by performing a huffing manoeuvre
(a forced expiration against open glottis), although the cough is
less effective [4], [17], [28]. Maximum expiratory pressure is a
commonly used parameter to assess the strength of respiratory
muscles [7], [8], and has been shown to positively correlate
with improved cough capacity [29]–[31].
In voluntary experiments, the peak cough pressure and
flow from both control group and laryngectomy groups are
lower than average published values in healthy adults [8],
[17]. This is attributed to the tubing in the system as well
as the presence of the solenoid valve restricting air flow.
The 102cm respiratory tube represents a total dead volume
in the RoboCough of approximately 0.39 litres, which is
approximately 6.5 % of an average male’s lung capacity
and 9.3 % of an average female’s lung capacity [32]. Other
possible causes could be leakage around mouthpieces during
coughing experiments and coughing while not fully prepared.
Additionally, while undertaking the experiments, participants
were asked to cough 5 times consecutively into the tube. This
could result in a decrease in peak cough flow rate and pressure
due to tiredness.
The control and post-laryngectomy groups had different age
profiles, and age related factors were not taken into account
when analysing the results. According to Cardoso et al [33],
as age increases, peak cough flow decreases. However, the
post-laryngectomy group (median age 72) had comparable
PCP values to the control group (median age 28). This
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may be due to the post-laryngectomy group having stronger
diaphram muscles than non-laryngecotomies of the same age
group because they may use a technique called diaphragmatic
breathing (also called abdominal breathing) to help breathing
and coughing after laryngectomy [34].
In this study, pressure thresholds were set by each post-
laryngectomy participant and were subjective and limited to
voluntary cough manoeuvres. An alternative way of control-
ling the opening of the valve is to assess the activity of
expiratory and accessory muscles through real-time EMG
monitoring. Research have shown ways to characterise the
difference between voluntary and reflex coughs using EMG
signals [35]. The integration of an EMG signal into the
valve control would expand the capability of the RoboCough
to wider coughing scenarios. Replacing the solenoid valve
with a valve with lower restriction could potentially increase
cough effectiveness due to the reduced pressure drop across
the valve [11]. Further investigation will also be carried out
to quantify the relationship between peak cough pressure,
threshold pressure, cough acceleration and peak flow rate
produced by the RoboCough.
Results from this study show that RoboCough is a promising
approach to increasing cough efficiency. It shows a comparable
PCF increase to using MI-E and MI-E + MAC methods,
although less effective than using IPPB + MAC in neuromus-
cular patients [14], [36]. RoboCough could be integrated in
patient’s everyday life easily as it can be light weight, easy
to use and each component are separable for handling. In rare
cases where one has set the threshold pressure too high such
that the valve may not open, the patient can either simply move
the connector tube away to breathe, or press the emergency
stop button and the valve will open. Scaling it down to the
size of a peak flow meter (approximately 22cm long and 6cm
wide) could effectively aid larygecotomy patients to cough
when needed and the ultimate goal is to integrate RoboCough
into a comfortable, wearable device.
V. CONCLUSION
This paper presents an approach to assist post laryngec-
tomy patients cough more effectively. The rationale is that
increasing the coughing pressure and flow rate would increase
coughing effectiveness. This is usually achieved by increasing
the strength of respiratory muscles, but this can take significant
time and training effort, and without a natural glottis, coughing
effectiveness remains low. In this study, we explored an novel
alternative, where an increase in the strength of an artificial
glottis closure increases coughing pressure and peak air flow.
To achieve this we designed and built the RoboCough, which
mimics the function of the glottis. We then tested and com-
pared the peak cough flow and peak cough pressure in control
and post-laryngectomy groups through a series of respiratory
experiments. Results show a significant increase in peak cough
pressure, flow rate and acceleration in the control group.
Using the RoboCough, post-laryngectomy coughs achieved
similar peak cough flow to the control group’s natural cough,
showing an improvement in their coughing capabilities. As
a first step towards a fully autonomous and bio-integrated
bionic device for full function restoration, this work paves the
way for new treatments for cough insufficiency in respiratory
disease sufferers and may additionally have potential for the
rehabilitation of coughing following respiratory conditions
such as COVID19.
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